ClinicalTrials.Veeva

Menu

White Spot Lesions Prevention During Orthodontic Fixed Appliance Treatment: a Randomized Clinical Trial

U

University of Baghdad

Status and phase

Unknown
Phase 3

Conditions

White Spot Lesion of Tooth

Treatments

Drug: Control primer
Drug: nCaF2 primer

Study type

Interventional

Funder types

Other

Identifiers

NCT04994314
calcium fluoride nanoparticles

Details and patient eligibility

About

The aim of this study is to evaluate the effectiveness of calcium fluoride nanoparticles containing orthodontic primer in preventing or decreasing the incidence WSLs over a period of 6 months in patients with fixed orthodontic appliances.

This study proposed to be double blinded, split mouth, randomized clinical trial, with equal randomization (1:1 allocation ratio).

Full description

The sample was selected and recruited from patients attending two centres (Orthodontic Department at Karbala Governmental Specialized Dental Center and Almina Dental Private Clinics/Karbala), but the bonding and follow up sessions were done in Almina Dental Private Clinics/Karbala. Patient recruitment was done according to specified inclusion and exclusion criteria.

Intervention procedure planned to be by bonding fixed orthodontic appliances to all patients. The four quadrants of the mouth will be divided into two groups (Group 1 and 2), with one group, the upper right and lower left quadrants bonded with nCaF2 resin, while the upper left and lower right quadrants bonded with control resin. For the other group, the reverse will be carried out. Then, by the use of a computer random number generator, the two groups will be randomly allocated, and each number in the random table will be given a study number in order to create the final Allocation Table for the participants in the study (which contained the study number and allocation group). the primary planned to be measured by DIAGNOdent Pen 2190 device to measure enamel demineralization objectively, while the secondary objective planned to be quantitative detection of Streptococcus mutans bacteria by using real-time PCR

Enrollment

31 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients have

    1. Fully erupted permanent teeth (regardless the third molar),
    2. Indication to have orthodontic treatment without extraction
    3. Fair or good oral hygiene before or after oral hygiene instruction

Exclusion criteria

  • Patients will be excluded if they had

    1. Previous orthodontic treatment or extractions
    2. Missing teeth
    3. Active enamel caries determined by clinical examination
    4. Patients with enamel hypoplasia, dental fluorosis or tetracycline pigmentation
    5. Labial restorations
    6. Severe periodontal diseases determined according to PDI index by Sigurd P. Ramfjord (Ramfjord, 1967)
    7. Craniofacial syndromes such as clefts
    8. Xerostomia determined from clinical history of the patient
    9. Severely rotated teeth (limiting the appearance of buccal surfaces)
    10. Heavy smokers determined by accounting the number of cigarettes per day and time to the first cigarette of the day (Heatherton et al., 1989) .

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

31 participants in 2 patient groups, including a placebo group

orthodontic primer containing calcium fluoride nanoparticles
Active Comparator group
Description:
Fixed appliance for ten maxillary teeth and the contralateral mandibular teeth will be bonded using orthodontic primer containing calcium fluoride nanoparticles
Treatment:
Drug: nCaF2 primer
Control primer
Placebo Comparator group
Description:
Fixed appliance for ten maxillary teeth (contralateral to experimental ten side)and the contralateral mandibular teeth will be bonded using conventional primer (TransbondTM XT orthodontic primers (3M-Unitek, Monrovia, USA)
Treatment:
Drug: Control primer

Trial contacts and locations

1

Loading...

Central trial contact

Rawof R. Al Tuma, MSc; Yassir A. Yassir, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems